ALLO Stock-Based Compensation
Allogene Therapeutics Inc · Stock-Based Compensation
ALLO Stock-Based Compensation
Latest reported$37.49Mperiod ending
ALLO Stock-Based Comp ($0.00 → $37.49M)
Annual stock-based compensation
High-resolution chart · PNG
ALLO stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 37,642,000 | |
| 51,743,000 | |
| 65,951,000 | |
| 83,600,000 | |
| 80,818,000 | |
| 65,261,000 | |
| 46,063,000 | |
| 18,566,000 | |
| 0 |